- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 231/04 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
Patent holdings for IPC class C07D 231/04
Total number of patents in this class: 55
10-year publication summary
1
|
3
|
3
|
7
|
2
|
4
|
5
|
4
|
4
|
0
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
BASF SE | 20892 |
5 |
The General Hospital Corporation | 4715 |
4 |
The Broad Institute, Inc. | 1793 |
4 |
Massachusetts Institute of Technology | 10030 |
3 |
The Feinstein Institute for Medical Research | 252 |
3 |
FMC Corporation | 847 |
3 |
FUJIFILM Corporation | 29295 |
2 |
Children's Medical Center Corporation | 1861 |
2 |
Council of Scientific & Industrial Research | 1424 |
2 |
National Institute of Biological Sciences, Beijing | 97 |
2 |
Neuropro Therapeutics, Inc. | 20 |
2 |
Tokyo Ohka Kogyo Co., Ltd. | 1549 |
2 |
Psy Therapeutics, Inc. | 14 |
2 |
Janssen Pharmaceutica N.V. | 3396 |
1 |
Centre National de La Recherche Scientifique | 10408 |
1 |
The Board of Trustees of the Leland Stanford Junior University | 6396 |
1 |
The Regents of the University of Michigan | 4676 |
1 |
The Trustees of the University of Pennsylvania | 4314 |
1 |
Argusina, Inc. | 2 |
1 |
Assistance Publique - Hopitaux de Paris | 997 |
1 |
Other owners | 12 |